Yale Bulletin and Calendar

January 12, 2001Volume 29, Number 15



BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

PRODUCTION SCHEDULE

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Study: Anti-depressant use renews
cell growth in critical area of brain

Continued use of anti-depressants leads to new cell growth in an area of the brain known to suffer cell death and atrophy as a result of depression and stress, a study by Yale researchers shows.

Depression affects an estimated 12% to 17% of the population at some point during an individual's lifetime. Anti-depressants are commonly prescribed for depression and other affective disorders, but the drugs' therapeutic effects on the molecular and cellular level are not clearly understood.

"The findings of our study are that chronic administration of anti-depressants increases the number of neurons in the adult hippocampal area," says Dr. Ronald Duman, professor of psychiatry and pharmacology. "This could explain in part how anti-depressants produce their therapeutic response." Duman was senior author of the study, published Dec. 15 in The Journal of Neuroscience.

The hippocampus is part of the limbic brain that is involved in learning, memory, mood and emotion. It is one of only a few regions of the brain where production of neurons occurs in the adult brain of animals, including humans. Several studies have demonstrated that stressful experiences, both physical and psychological, lead to neuronal loss or atrophy in the hippocampus. Other studies show that anti-depressants can block this cell loss.

"In humans, brain imaging studies demonstrate that in patients with depression or post-traumatic stress syndrome there is a decrease in volume of the hippocampus that is thought to be related to the neuronal atrophy and loss," Duman says. "The results of our study demonstrate that anti-depressants can reverse or block further loss of neurons in the hippocampus by increasing neurogenesis [new cell growth]."

Duman's laboratory has been studying the mechanism of action of anti-depressants in rodents for over 15 years. The researchers have focused on cellular actions of anti-depressants, looking at the role of the intracellular signal transduction pathways that control neuronal function. They have identified several actions of anti-depressants which indicate that anti-depressants influence the survival or the number of neurons in the hippocampus.

This study was intended to look at whether the anti-depressants increased the birth of neurons in the hippocampus. The researchers tested several different classes of anti-depressant drugs, as well as electroconvulsive seizure therapy (ECS), and an anti-psychotic medication.

ECS is clinically the most effective treatment for cases of depression that are resistant to available drug treatments. As expected, repeated administration of ECS increased the number of neurons in the hippocampus of the brain by 50%. The chemical anti-depressants tested increased the number of neurons in the same area by 20% to 40%.

The anti-depressants that were administered included a monoamineoxidase in-hibitor (tranlcypromine), a serotonin-selective reuptake inhibitor (fluoxetine), and a norepinephrine-selective reuptake in-hibitor (reboxetine).

However, brief (one to five days) administration of the anti-depressants did not lead to any significant cell change. Results were seen after 14 to 28 days of administration, which is consistent with treatment regimens for the therapeutic response to anti-depressants.

Administration of the anti-psychotic drug haloperidol, which is a non-antidepressant psychotropic drug, also did not produce any significant cell change in this area of the brain. In addition, the researchers recently have demonstrated that morphine, another non-antidepressant psychotropic drug, decreases the number of cells in the hippocampal area.

Co-authors of the study were Jessica Malberg, first author, and Amelia Eisch, both postdoctoral fellows in psychiatry, and Eric Nestler, formerly a professor of psychology, pharmacology and neurobiology at Yale.

-- By Jacqueline Weaver


T H I SW E E K ' SS T O R I E S

Scientists find debris from ancient galaxies in Milky Way

Team identifies 168 young stars in nearby Orion complex

National Humanities Medal awarded to historian Morgan

'Up With a Shout!' will celebrate Judeo-Christian songbook of psalms

Study: Anti-depressant use renews cell growth in critical area of brain

Recently honored expert shares views on health care policy

New deans are appointed at two colleges

Exhibit explores how the past serves as inspiration for contemporary Asian artists

Post-war corporate landmarks are focus of events


MEDICAL SCHOOL NEWS

Noted visiting faculty members to present talks

Drama School students to stage political satire that was once suppressed in Russia

Yale Opera presents epic of love, intrigue

Mexican cabaret artist brings 'rowdy' show to Yale Rep

Concert to feature 'America's greatest living composer'

Blue-White World: A Photo Essay

CMI offers grants for interactive media projects that bolster learning

Bulldogs to meet Fighting Irish at Coliseum

Campus Notes

In the News

Yale Scoreboard



Bulletin Home|Visiting on Campus| Calendar of Events|Bulletin Board

Classified Ads|Search Archives|Production Schedule|Bulletin Staff

Public Affairs Home|News Releases| E-Mail Us|Yale Home Page